Education for Healthcare Professionals
We are committed to working with healthcare professionals to ensure patients receive the best treatment and care.
The rapid change of pace in research and treatments for amyloidosis makes it vital that healthcare professionals have access to up-to-date information on best practices. We provide unique resources and tailored information for doctors, nurses and other clinicians.
We collaborate with amyloidosis experts from around the world to design educational tools that provide clinicians with easy access to the most current information on scientific and clinical advances to help achieve earlier diagnosis and therapeutic intervention.
Physician Education & Tools
ARC Cardiac Amyloidosis Alert Card
This easy-to-use pocket card identifies “low voltage” EKGs in combination with ECHO images of increased ventricular mass, which are very...
Cardiac Amyloidosis: Stop Missing It! (CME/CE)
This symposium will provide a brief overview of cardiac amyloidosis, current guidelines and emerging options for treatment, and how to...
Medscape CME & Education for Physicians
Medscape is the leading online global destination for physicians and healthcare professionals worldwide with the latest medical news and expert...
Clinical Resources APP
Learn how this valuable tool is giving healthcare professionals easy access to critical and current medical information and improving early and accurate diagnosis of amyloidosis.
The AAN Annual Meeting will take place in Philadelphia. Neurologic symptoms often proceed other symptoms of amyloidosis, and yet fewer neurologists are making the diagnosis than other specialists. Amyloidosis sessions will focus on earlier diagnosis.
May 11 2019
Diagnosing Amyloidosis: From Cardiology to Neurology
The Amyloid Clinic at Emory's Diagnosing Amyloidosis Symposium is for primary care providers, neurologists, cardiologists and hematologists. The Emory University School of Medicine designates this activity for a maximum of 3.25 AMA PRA Category 1 credits.
The objective of the Utah Amyloidosis Symposium is to develop a forum that will catalyze, advocate, and provide education that promotes change, development and improvement for the early diagnosis and management of amyloidosis.